- Free from Publisher J Rosenstock, AJ Ahmann, G Colon, J Scism- … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Baseline A1C was similar (PPT 8.8%; BBT 8.9%; P = 0.598). At week 24,
A1C was lower with BBT (6.78 vs. 6.95%, P = 0.021). A1C was reduced
significantly from baseline for both therapies (P < 0.0001). The difference ... Cited by 29 - Related articles - BL Direct - All 5 versions
RJMU Ligthelm, HLOM Lynggaard, CDC Fox, … - Experimental and Clinical Endocrinology and Diabetes, 2006 - 万方数据资源系统 AIMS: To show that a thrice daily meal-time biphasic insulin aspart (BIAsp)
treatment regimen is as efficacious as a 4 times daily basal-bolus regimen with
human isophane insulin (NPH) and insulin aspart (IAsp). METHODS: A ... Cited by 22 - Related articles - BL Direct - All 4 versions
C Kazda, H Hülstrunk, K Helsberg, F Langer, … - Journal of diabetes and its complications, 2006 - Elsevier This was an open-label, randomized, parallel, three-arm multicenter trial in
patients with type 2 diabetes starting insulin treatment. Patients (n=159) were
randomly assigned to 24-week treatment with 3× daily insulin lispro, 3× ... Cited by 26 - Related articles - All 10 versions
R Qayyum, S Bolen, N Maruthur, L Feldman, … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Evidence comparing premixed insulin analogues (a mixture of
rapid-acting and intermediate-acting insulin analogues) with other antidiabetic
agents is urgently required to guide appropriate therapy. Cited by 20 - Related articles - All 8 versions
DC Robbins, PJ Beisswenger, A Ceriello, RB … - Clinical therapeutics, 2007 - Elsevier Background: In people without diabetes, 50% of daily insulin secretion is basal
and the remainder is postprandial. Hence, it would be expected that insulin
replacement therapy in a 50/50 ratio with each meal would mimic physiologic ... Cited by 9 - Related articles - All 3 versions
SJ Jacober, JL Scism-Bacon, AJ Zagar… - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com Aim: In patients with type 2 diabetes, insulin therapy is commonly initiated
with either a single dose of basal insulin or twice-daily premixed (basal plus
prandial) insulin despite no widely accepted recommendation. We compared ... Cited by 14 - Related articles - BL Direct - All 4 versions
- ►pipex.com [PDF] RR Holman, KI Thorne, AJ Farmer, MJ Davies, … - New England Journal of Medicine, 2007 - content.nejm.org From the Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and
Metabolism (RRH, KIT, AJF, JFK, SP, JCL) and the Department of Primary Health
Care (AJF), University of Oxford, Oxford; and the Department of Cardiovas- ... Cited by 134 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] K Esposito, M Ciotola, MI Maiorino, R … - Annals of internal medicine, 2008 - Am Coll Physicians Background: Injection of long-acting insulin at bedtime is a com- mon
therapeutic approach for patients with type 2 diabetes that is poorly controlled
with oral regimens. Neutral protamine lispro (NPL) insulin has demonstrated ... Cited by 6 - Related articles - All 7 versions
K Horvath, K Jeitler, A Berghold, SH Ebrahim, … - Cochrane database of systematic reviews (Online), 2007 - ncbi.nlm.nih.gov BACKGROUND: Despite indications from epidemiological trials that higher blood
glucose concentrations are associated with a higher risk for developing micro-
and macrovascular complications, evidence for a beneficial effect of ... Cited by 72 - Related articles - BL Direct
